Compound Detail
CHEMBL591435
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)([O-])CP(=O)([O-])OP(=O)([O-])OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1.[Na+].[Na+].[Na+]
Basic Information
| ChEMBL ID | CHEMBL591435 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XVYYZHWWMCDQTR-LVDSEQKXSA-K |
| Parent Compound | CHEMBL1615710 |
| Active Moiety | CHEMBL1615710 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
846.6
MW (Da)
-1.01
ALogP
24
HBA
9
HBD
378.2
PSA (Ų)
0.04
QED
3
Ro5 Violations
14
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20175517 | 10.1021/jm901621h | P2Y purinoceptor 1 | 1 |
| 20175517 | 10.1021/jm901621h | ADMET | 1 |
Data from ChEMBL 36 via Core Engine